XTX Topco’s AbbVie ABBV Stock Holding History

XTX Topco’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,692	Closed	-$5.81M	–	4091
2026 Q1	$5.81M	Buy	26,692 +24,241	+989%	+$5.38M	0.1%	217
2025 Q4	$560K	Buy	2,451 +156	+7%	+$35.5K	0.01%	1492
2025 Q3	$531K	Sell	2,295 -18,837	-89%	-$3.84M	0.03%	1023
2025 Q2	$3.92M	Buy	+21,132	New	+$3.93M	0.16%	118
2023 Q4	–	Sell	-8,513	Closed	-$1.27M	–	1513
2023 Q3	$1.27M	Buy	+8,513	New	+$1.25M	0.22%	52
2023 Q1	–	Sell	-2,752	Closed	-$445K	–	1222
2022 Q4	$445K	Buy	+2,752	New	+$422K	0.09%	357
2022 Q2	–	Sell	-9,352	Closed	-$1.52M	–	812
2022 Q1	$1.52M	Buy	+9,352	New	+$1.36M	0.66%	12
2021 Q4	–	Sell	-2,857	Closed	-$308K	–	643
2021 Q3	$308K	Buy	+2,857	New	+$326K	0.1%	335

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

XTX Topco's ABBV Position: Q2 2026 in Review

XTX Topco sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 26,692 shares — an estimated $5.81M sold.

XTX Topco first reported a position in ABBV in Q3 2021 and held it in 8 quarters. The position peaked at $5.81M in Q1 2026. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

XTX Topco reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 26,692 AbbVie shares in Q2 2026, an estimated $5.81M.
XTX Topco first reported a position in AbbVie in Q3 2021 and held it in 8 quarters.
XTX Topco's AbbVie position peaked at $5.81M in Q1 2026.
4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.